Nervous system disorders: Very common: Headache.
Respiratory, thoracic and mediastinal disorders: Very common: Upper respiratory infection; Common: Lower respiratory infection.
Gastrointestinal disorders: Very common: Abdominal pain/discomfort, oily spotting from the rectum, flatus with discharge, faecal urgency, fatty/oily stool, flatulence, liquid stools, oily evacuation, increased defecation; Common: Rectal pain/discomfort, soft stools, faecal incontinence, abdominal distension*, tooth disorder, gingival disorder.
Renal and urinary disorders: Common: Urinary tract infection.
Metabolism and nutrition disorders: Very common: Hypoglycemia*.
Infections and infestations: Very common: Influenza.
General disorders and administration site conditions: Common: Fatigue.
Reproductive system and breast disorders: Common: Menstrual irregularity.
Psychiatric disorders: Common: Anxiety.
(* only unique treatment adverse events that occurred at a frequency of > 2% and with an incidence ≥ 1% above placebo in obese type 2 diabetic patients.)
View ADR Reporting Link